News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Cline Christopher R.
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 05/12/2023 |
4
| Cline Christopher R. (CFO) has filed a Form 4 on Travere Therapeutics, Inc.|
Txns:
| Sold 455 shares
@ $16.59, valued at
$7.5k
|
|
| 04/13/2023 |
4
| Cline Christopher R. (CFO) has filed a Form 4 on Travere Therapeutics, Inc.|
Txns:
| Sold 47 shares
@ $21.49, valued at
$1k
|
|
| 02/02/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/26/2023 |
4
| Cline Christopher R. (CFO) has filed a Form 4 on Travere Therapeutics, Inc.|
Txns:
| Sold 852 shares
@ $21.9044, valued at
$18.7k
|
|
| 09/01/2022 |
4
| Cline Christopher R. (CFO) has filed a Form 4 on Travere Therapeutics, Inc.|
Txns:
| Granted 5,000 shares
@ $0
Granted 48,000 options to buy
@ $28.06, valued at
$1.3M
Granted 9,840 options to buy
@ $0 |
|
| 09/01/2022 |
3
| Cline Christopher R. (CFO) has filed a Form 3 on Travere Therapeutics, Inc. |
|
|